Lusutrombopag Interactions
There are 150 drugs known to interact with lusutrombopag, along with 2 disease interactions. Of the total drug interactions, 4 are major, and 146 are moderate.
- View lusutrombopag disease interactions (2)
Medications known to interact with lusutrombopag
Note: Showing generic names only.
A
- abiraterone
- abrocitinib
- acalabrutinib
- afatinib
- alpelisib
- amiodarone
- apremilast
- asciminib
- astemizole
- atazanavir
- avacopan
- azithromycin
B
C
- C1 esterase inhibitor (human)
- cabozantinib
- capmatinib
- carfilzomib
- carvedilol
- ceritinib
- clarithromycin
- cobicistat
- conestat alfa
- conivaptan
- cyclosporine
D
E
- elacestrant
- elagolix
- eliglustat
- eltrombopag
- enasidenib
- encorafenib
- entrectinib
- enzalutamide
- erythromycin
- etravirine
- ezogabine
F
G
H
I
- ibritumomab
- ibrutinib
- idelalisib
- isavuconazonium
- istradefylline
- itraconazole
- ivacaftor
- ivosidenib
- ixabepilone
K
L
- lapatinib
- lasmiditan
- lazertinib
- lenacapavir
- lenalidomide
- leniolisib
- levoketoconazole
- lomitapide
- lovastatin
M
N
O
P
- pacritinib
- palbociclib
- pirtobrutinib
- pomalidomide
- ponatinib
- posaconazole
- pralsetinib
- progesterone
- propafenone
Q
R
S
- safinamide
- saquinavir
- sarecycline
- selpercatinib
- simeprevir
- simvastatin
- sonidegib
- sorafenib
- sotorasib
- sparsentan
- spironolactone
- suvorexant
T
- tacrolimus
- tafamidis
- tamoxifen
- tedizolid
- telaprevir
- telithromycin
- tepotinib
- terfenadine
- teriflunomide
- testosterone
- thalidomide
- ticagrelor
- tivozanib
- tolbutamide
- tolvaptan
- trifluoperazine
- trimethoprim
- troleandomycin
- tucatinib
U
V
Lusutrombopag disease interactions
There are 2 disease interactions with lusutrombopag which include:
More about lusutrombopag
- lusutrombopag consumer information
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: platelet-stimulating agents
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.